NCT04004416 Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Status COMPLETED Phase PHASE4
NCT04002258 Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment Status COMPLETED Phase N/A
NCT03999112 Effect of Metacognitive Therapy on Negative Symptoms: a Case Series Status UNKNOWN Phase NA
NCT03978832 Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone Status COMPLETED Phase PHASE4
NCT03975400 Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis Status COMPLETED Phase NA
NCT03974620 Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia Status NOT_YET_RECRUITING Phase NA
NCT03973853 How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia Status WITHDRAWN Phase NA
NCT03967431 Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03965598 Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group Status UNKNOWN Phase N/A
NCT03953664 The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03943537 Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders Status COMPLETED Phase PHASE2